NCT05170074

Brief Summary

National, multicentre observational study on surgical reconstruction of the anterior and apical compartment of the pelvic floor with an SRS implant

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
175

participants targeted

Target at P50-P75 for all trials

Timeline
4mo left

Started Apr 2022

Longer than P75 for all trials

Geographic Reach
1 country

7 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
Apr 2022Sep 2026

First Submitted

Initial submission to the registry

December 9, 2021

Completed
18 days until next milestone

First Posted

Study publicly available on registry

December 27, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

April 7, 2022

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Expected
Last Updated

April 2, 2025

Status Verified

March 1, 2025

Enrollment Period

3.4 years

First QC Date

December 9, 2021

Last Update Submit

March 28, 2025

Conditions

Keywords

SRS ImplantQuality of LifePelvic Organ ProlapseSurgical Reconstruction

Outcome Measures

Primary Outcomes (1)

  • Patient´s Quality of Life

    Evaluation of changes in quality of life twelve months after implantation of the SRS implant compared to baseline. Quality of Life was assessed by the P-QOL (Prolapse Quality of Life Questionnaire). The P-QOL yields a domain score in the range from zero to 100, wheras a score of zero is the best.

    12 months

Study Arms (1)

SRS implant

Surgical reconstruction of the anterior and apical compartment of the pelvic floor with an SRS implant

Eligibility Criteria

Age21 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Women with a symptomatic anterior vaginal wall prolapse with/without apex/uterine prolapse ≥ stage II (according to POP-Q system), transvaginal SRS implantation for pelvic organ prolapse surgery

You may qualify if:

  • Women with a symptomatic anterior vaginal wall prolapse with/without apex/uterine prolapse ≥ stage II (according to POP-Q system). This applies to primary as well as recurrent intervention.
  • Age ≥ 21 years.
  • Patient is mentally able to understand the nature, aims, or possible consequences of the PMCF study.
  • Patient information has been provided and written consent exists.

You may not qualify if:

  • Contraindications according to the manufacturer's instructions for use.
  • Patient with previous urogynaecological surgeries with alloplastic material.
  • Patient with radiological treatment in the pelvic floor.
  • Patient is institutionalised by court or official order (MPDG §27).
  • Participation in another interventional study concerning pelvic floor reconstruction.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

Heilig Geist-Hospital

Bensheim, Hesse, 64625, Germany

Location

Universitätsklinikum Augsburg

Augsburg, 86156, Germany

Location

Evangelisches Krankenhaus Hagen-Haspe

Hagen, 58135, Germany

Location

Asklepios Klinik Altona

Hamburg, 22763, Germany

Location

Städtisches Krankenhaus Kiel

Kiel, 24116, Germany

Location

Marienhaus Klinikum Hetzelstift Neustadt/Weinstraße

Neustadt, 67434, Germany

Location

Klinikum Oberlausitzer Bergland gGmbH

Zittau, 02763, Germany

Location

Related Publications (2)

  • Levy G, Padoa A, Marcus N, Beck A, Fekete Z, Cervigni M. Anchorless implant for the treatment of advanced anterior and apical vaginal prolapse - Medium term follow up. Eur J Obstet Gynecol Reprod Biol. 2020 Mar;246:55-59. doi: 10.1016/j.ejogrb.2020.01.005. Epub 2020 Jan 9.

    PMID: 31954369BACKGROUND
  • Levy G, Padoa A, Fekete Z, Bartfai G, Pajor L, Cervigni M. Self-retaining support implant: an anchorless system for the treatment of pelvic organ prolapse-2-year follow-up. Int Urogynecol J. 2018 May;29(5):709-714. doi: 10.1007/s00192-017-3415-3. Epub 2017 Jul 14.

    PMID: 28710613BACKGROUND

Related Links

MeSH Terms

Conditions

Pelvic Organ Prolapse

Condition Hierarchy (Ancestors)

ProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Tina Cadenbach-Blome, Dr. med.

    Asklepios Klinik Altona

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 9, 2021

First Posted

December 27, 2021

Study Start

April 7, 2022

Primary Completion

September 1, 2025

Study Completion (Estimated)

September 1, 2026

Last Updated

April 2, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations